Search research articles
Contact Us
Filters
Showing results (81-90 of 149) with videos related to
Page
of 15
Sort By:
Scientific Reports
|
July 14, 2019
Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease
Nobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, et al.
Oncology
|
January 10, 2014
Reduced organic anion transporter expression is a risk factor for hepatocellular carcinoma in chronic hepatitis C patients: a propensity score matching study
Yutaka Yasui, Atsushi Kudo, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 18, 2024
Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease
Keito Suzuki, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
June 8, 2013
Prospective comparison of real-time tissue elastography and serum fibrosis markers for the estimation of liver fibrosis in chronic hepatitis C patients
Nobuharu Tamaki, Masayuki Kurosaki, Shuya Matsuda, et al.
Plos One
|
February 23, 2022
The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy
Kenta Takaura, Masayuki Kurosaki, Kento Inada, et al.
Journal of Viral Hepatitis
|
April 12, 2019
Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antivirals
Nobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, et al.
BMC Gastroenterology
|
June 17, 2023
Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
Shun Ishido, Nobuharu Tamaki, Yuka Takahashi, et al.
Journal of Gastroenterology and Hepatology
|
June 21, 2021
Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease
Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, et al.
Cancer
|
October 15, 2013
Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma
Kaoru Tsuchiya, Yasuhiro Asahina, Shuya Matsuda, et al.
Journal of Gastroenterology and Hepatology
|
April 25, 2019
Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate
Shun Kaneko, Masayuki Kurosaki, Nobuharu Tamaki, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 149) with videos related to
Sort By:
Page
of 15
Scientific Reports
|
July 14, 2019
Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease
Nobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, et al.
Oncology
|
January 10, 2014
Reduced organic anion transporter expression is a risk factor for hepatocellular carcinoma in chronic hepatitis C patients: a propensity score matching study
Yutaka Yasui, Atsushi Kudo, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 18, 2024
Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease
Keito Suzuki, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
June 8, 2013
Prospective comparison of real-time tissue elastography and serum fibrosis markers for the estimation of liver fibrosis in chronic hepatitis C patients
Nobuharu Tamaki, Masayuki Kurosaki, Shuya Matsuda, et al.
Plos One
|
February 23, 2022
The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy
Kenta Takaura, Masayuki Kurosaki, Kento Inada, et al.
Journal of Viral Hepatitis
|
April 12, 2019
Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antivirals
Nobuharu Tamaki, Mayu Higuchi, Masayuki Kurosaki, et al.
BMC Gastroenterology
|
June 17, 2023
Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
Shun Ishido, Nobuharu Tamaki, Yuka Takahashi, et al.
Journal of Gastroenterology and Hepatology
|
June 21, 2021
Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease
Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, et al.
Cancer
|
October 15, 2013
Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma
Kaoru Tsuchiya, Yasuhiro Asahina, Shuya Matsuda, et al.
Journal of Gastroenterology and Hepatology
|
April 25, 2019
Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate
Shun Kaneko, Masayuki Kurosaki, Nobuharu Tamaki, et al.
Page
of 15